Isofair
Indicated for severe acne developed to alleviate chronic skin inflammation.
Strengths: 10 · 20mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Roaccutane; Isotretinoin Accord
- Therapeutic class
Systemic Retinoid
- Pharmacological class
Retinoid
- Minor side effects
xerostomia; cheilitis; dry eyes; epistaxis
- Moderate side effects
myalgia; arthralgia; elevated liver enzymes
- Dosage forms
Capsule, soft
- Administration route
Oral use
- Patient summary
Indicated for severe acne developed to alleviate chronic skin inflammation.
- Prescription status
POM
- Manufacturer
Roche
- Onset Time
2–4 weeks
- Duration
16–24 weeks
- Storage instructions
Store in a cool, dry place, protected from light.
- Drug interactions
tetracyclines; vitamin a
- Age restrictions
Not for use in prepubertal children.
Contraindications
pregnancy; breastfeeding; hepatic impairment; hypervitaminosis a; hyperlipidaemia
Precautions and warnings
avoid blood donation during treatment; monitor liver function tests; avoid laser skin treatments
Serious side effects
depression — requires immediate medical attention; pancreatitis — requires immediate medical attention; teratogenicity — requires immediate medical attention
Mechanism of action
Isotretinoin reduces sebum production and size of sebaceous glands, inhibiting bacterial proliferation and promoting anti-inflammatory activity on the skin.
Pregnancy and breastfeeding
Pregnancy: Strictly contraindicated; highly teratogenic. Breastfeeding: Contraindicated.
Isofair
Indicated for severe acne developed to alleviate chronic skin inflammation.
Editorial Notes
- Active ingredient(s): Isotretinoin
- Listed indication(s): Severe Acne, Acne Conglobata
Usually available as
- 90 tablets - 10 mg1070-10-mg-13283
- 90 tablets - 20 mg1070-20-mg-13288